China Approves Gilead's Genvoya for HIV-1 Infection

China Approves Gilead's Genvoya for HIV-1 Infection

Source: 
CP Wire
snippet: 
  • Genvoya is the first TAF-based single tablet regimen for the treatment of HIV to be approved in China
  • There were approximately 140,000 people newly diagnosed with HIV in China as of 2017
  • Genvoya has already become the most-prescribed regimen for both treatment-naïve and switch patients